YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2023	AI Evaluation of Stenosis on Coronary CTA, Comparison With Quantitative Coronary Angiography and Fractional Flow Reserve: A CREDENCE Trial Substudy	JACC-CARDIOVASCULAR IMAGING
2023	Analysis of the gut microbiome using extracellular vesicles in the urine of patients with colorectal cancer	KOREAN JOURNAL OF INTERNAL MEDICINE
2023	Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2023	A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation	CANCER
2023	Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study	JOURNAL OF CLINICAL ONCOLOGY
2023	Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer	NATURE COMMUNICATIONS
2023	Low skeletal muscle mass is associated with mortality in kidney transplant recipients	AMERICAN JOURNAL OF TRANSPLANTATION
2023	Diabetes, Atherosclerosis, and Stenosis by AI	DIABETES CARE
2023	Evaluation of an air quality warning system for vulnerable and susceptible individuals in Korea: an interrupted time series analysis	EPIDEMIOLOGY AND HEALTH
2023	Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes	FRONTIERS IN ENDOCRINOLOGY
2023	Chest X-ray-based opportunistic screening of sarcopenia using deep learning	JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
2023	CAGE-B and SAGE-B models better predict the hepatitis B virus-related hepatocellular carcinoma after 5-year entecavir treatment than PAGE-B	JOURNAL OF DIGESTIVE DISEASES
2023	Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Patients With and Without Diabetes : Long-Term Outcomes From the CONFIRM Registry	HEART LUNG AND CIRCULATION
2023	The association between autoantibody types and salivary gland hypofunction in patients with primary Sjögren's syndrome	JOURNAL OF ORAL PATHOLOGY & MEDICINE
2023	BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia-Pacific region	HIV MEDICINE
2023	CD4/CD8 Ratio Recovery Among People Living With HIV Starting With First-Line Integrase Strand Transfer Inhibitors: A Prospective Regional Cohort Analysis	JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2023	The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus	KIDNEY INTERNATIONAL
2023	INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)	BMC CANCER
2023	Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma	CANCER IMMUNOLOGY IMMUNOTHERAPY
2023	Preface	CLINICAL AND MOLECULAR HEPATOLOGY